Lastly, we evaluated the therapeutic effect of intravenous HMGB1 administration in a mouse model of allergic contact dermatitis (ACD), one of the most common inflammatory skin diseases. This evidence concerns the gene HMGB1 and granular corneal dystrophy type II.